S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
T   37.47 (-0.29%)
ACB   3.51 (-4.62%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
T   37.47 (-0.29%)
ACB   3.51 (-4.62%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
Log in

Danaher Stock Price, News & Analysis (NYSE:DHR)

$138.80
+0.08 (+0.06 %)
(As of 10/14/2019 04:00 PM ET)
Today's Range
$138.42
Now: $138.80
$140.00
50-Day Range
$135.40
MA: $141.08
$146.47
52-Week Range
$94.59
Now: $138.80
$147.33
Volume1.12 million shs
Average Volume2.51 million shs
Market Capitalization$99.57 billion
P/E Ratio30.71
Dividend Yield0.49%
Beta0.94
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. Read More…

Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryIndustrial Conglomerates
SectorMulti-Sector Conglomerates
CUSIP23585110
Phone202-828-0850

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$19.89 billion
Cash Flow$6.44 per share
Book Value$40.27 per share

Profitability

Net Income$2.65 billion

Miscellaneous

Employees71,000
Market Cap$99.57 billion
Next Earnings Date10/17/2019 (Estimated)
OptionableOptionable

Receive DHR News and Ratings via Email

Sign-up to receive the latest news and ratings for DHR and its competitors with MarketBeat's FREE daily newsletter.


Danaher (NYSE:DHR) Frequently Asked Questions

What is Danaher's stock symbol?

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Danaher announced a quarterly dividend on Tuesday, September 10th. Stockholders of record on Friday, September 27th will be given a dividend of $0.17 per share on Friday, October 25th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.49%. The ex-dividend date is Thursday, September 26th. View Danaher's Dividend History.

How were Danaher's earnings last quarter?

Danaher Co. (NYSE:DHR) issued its earnings results on Thursday, July, 18th. The conglomerate reported $1.19 EPS for the quarter, beating analysts' consensus estimates of $1.15 by $0.04. The conglomerate had revenue of $5.16 billion for the quarter, compared to analyst estimates of $5.09 billion. Danaher had a net margin of 12.22% and a return on equity of 11.53%. The business's quarterly revenue was up 3.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.15 earnings per share. View Danaher's Earnings History.

When is Danaher's next earnings date?

Danaher is scheduled to release their next quarterly earnings announcement on Thursday, October 17th 2019. View Earnings Estimates for Danaher.

What guidance has Danaher issued on next quarter's earnings?

Danaher issued an update on its FY19 earnings guidance on Thursday, July, 18th. The company provided EPS guidance of $4.75-4.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.85.

What price target have analysts set for DHR?

13 brokerages have issued 12 month price targets for Danaher's shares. Their forecasts range from $110.00 to $174.00. On average, they anticipate Danaher's stock price to reach $146.23 in the next twelve months. This suggests a possible upside of 5.3% from the stock's current price. View Analyst Price Targets for Danaher.

What is the consensus analysts' recommendation for Danaher?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 2 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Danaher.

Has Danaher been receiving favorable news coverage?

Media coverage about DHR stock has trended negative this week, according to InfoTrie. The research firm rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Danaher earned a media sentiment score of -2.8 on InfoTrie's scale. They also gave media headlines about the conglomerate a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Danaher.

Are investors shorting Danaher?

Danaher saw a increase in short interest during the month of September. As of September 30th, there was short interest totalling 5,030,000 shares, an increase of 10.5% from the August 30th total of 4,550,000 shares. Based on an average daily trading volume, of 2,280,000 shares, the days-to-cover ratio is presently 2.2 days. Approximately 0.8% of the shares of the company are short sold. View Danaher's Current Options Chain.

Who are some of Danaher's key competitors?

What other stocks do shareholders of Danaher own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), Home Depot (HD), Walt Disney (DIS), Starbucks (SBUX), Johnson & Johnson (JNJ), Alphabet (GOOG), CVS Health (CVS), Alibaba Group (BABA), UnitedHealth Group (UNH) and Cisco Systems (CSCO).

Who are Danaher's key executives?

Danaher's management team includes the folowing people:
  • Mr. Thomas P. Joyce Jr., CEO, Pres & Director (Age 58)
  • Mr. Daniel L. Comas, Exec. VP (Age 55)
  • Mr. William K. Daniel II, Exec. VP (Age 54)
  • Mr. Rainer M. Blair, Exec. VP (Age 55)
  • Mr. Joakim Weidemanis, Exec. VP (Age 49)

Who are Danaher's major shareholders?

Danaher's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Welch & Forbes LLC (0.10%), Gofen & Glossberg LLC IL (0.04%), Riverbridge Partners LLC (0.03%), Polaris Greystone Financial Group LLC (0.03%), Capital Investment Services of America Inc. (0.02%) and Chesley Taft & Associates LLC (0.02%). Company insiders that own Danaher stock include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Institutional Ownership Trends for Danaher.

Which institutional investors are selling Danaher stock?

DHR stock was sold by a variety of institutional investors in the last quarter, including TIAA FSB, National Investment Services Inc. WI, Baldwin Brothers Inc. MA, Banyan Capital Management Inc., Gofen & Glossberg LLC IL, West Oak Capital LLC, Webster Bank N. A. and Welch & Forbes LLC. Company insiders that have sold Danaher company stock in the last year include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Donald J Ehrlich, Linda P Hefner, Matthew Mcgrew, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Insider Buying and Selling for Danaher.

Which institutional investors are buying Danaher stock?

DHR stock was acquired by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Pacer Advisors Inc., Park National Corp OH, Riverbridge Partners LLC, Legacy Private Trust Co., Bangor Savings Bank, Dubuque Bank & Trust Co. and Crossmark Global Holdings Inc.. View Insider Buying and Selling for Danaher.

How do I buy shares of Danaher?

Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Danaher's stock price today?

One share of DHR stock can currently be purchased for approximately $138.81.

How big of a company is Danaher?

Danaher has a market capitalization of $99.58 billion and generates $19.89 billion in revenue each year. The conglomerate earns $2.65 billion in net income (profit) each year or $4.52 on an earnings per share basis. Danaher employs 71,000 workers across the globe.View Additional Information About Danaher.

What is Danaher's official website?

The official website for Danaher is http://www.danaher.com/.

How can I contact Danaher?

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]


MarketBeat Community Rating for Danaher (NYSE DHR)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  879 (Vote Outperform)
Underperform Votes:  507 (Vote Underperform)
Total Votes:  1,386
MarketBeat's community ratings are surveys of what our community members think about Danaher and other stocks. Vote "Outperform" if you believe DHR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DHR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/14/2019 by MarketBeat.com Staff

Featured Article: Front-End Load

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel